Singapore – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...
Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...
Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes ...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused...
Singapore – The FDA grants 510(k) clearance for Bio-Rad Laboratories' IH-Reader 24, a semi-automated blo...
Singapore – Aimed at satisfying European Commission (EC) concerns about the potential overlap in the inflammatory ...
EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...
Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...
M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...
ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...
Bain Capital and Pfizer have announced the creation of Cerevel Therapeutics, a new biopharmaceutical company...
AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...
Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...
Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...
Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...
Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...
AstraZeneca and Merck have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...
